| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Aurobindo Pharma Limited | 2026-10-08 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Laurus Labs Limited | 2026-09-18 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Macleods Pharmaceuticals Limited | 2026-09-17 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2026-09-14 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2026-09-14 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV), for oral use Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2026-07-29 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Mylan Pharmaceuticals Inc. | 2026-07-15 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2026-07-08 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Major Pharmaceuticals | 2026-03-13 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2026-03-12 |
| These highlights do not include all the information needed to use ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for ZIDOVUDINE TABLETS. ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1987 | Product name | Coupler LLC | 2026-01-19 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Laurus Labs Limited | 2026-01-12 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Strides Pharma Science Limited | 2026-01-05 |
| Lamivudine Oral Solution These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution Initial U.S. Approval: 1995 | Product name | Chartwell Govermental & Specialty RX, LLC. | 2026-01-02 |
| LAMIVUDINE oral solution These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution Initial U.S. Approval: 1995 | Product name | Chartwell RX, LLC | 2025-12-30 |
| LAMIVUDINE TABLETS. These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Golden State Medical Supply, Inc. | 2025-11-24 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2025-10-29 |
| These highlights do not include all the information needed to use DOVATO safely and effectively. See full prescribing information for DOVATO. DOVATO (dolutegravir and lamivudine) tablets, for oral use Initial U.S. Approval: 2019 | Product name | ViiV Healthcare Company | 2025-10-29 |
| These highlights do not include all the information needed to use DOVATO safely and effectively. See full prescribing information for DOVATO. DOVATO (dolutegravir and lamivudine) tablets, for oral use Initial U.S. Approval: 2019 | Product name | ViiV Healthcare Company | 2025-10-29 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | Product name | ViiV Healthcare Company | 2025-10-29 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | Product name | PD-Rx Pharmaceuticals, Inc. | 2025-10-17 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Micro Labs Limited | 2025-10-16 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2025-09-19 |
| LAMIVUDINE TABLETS (HBV). These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Golden State Medical Supply, Inc. | 2025-08-12 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Micro Labs Limited | 2025-07-28 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2025-06-17 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2025-06-12 |
| These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2025-05-31 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Strides Pharma Science Limited | 2025-03-27 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 2004 | Product name | Macleods Pharmaceuticals Limited | 2025-03-03 |
| These highlights do not include all the information needed to use ZIDOVUDINE CAPSULES safely and effectively. See full prescribing information for ZIDOVUDINE CAPSULES. ZIDOVUDINE capsules, for oral use Initial U.S. Approval: 1987 | Product name | Aurobindo Pharma Limited | 2025-02-10 |
| These highlights do not include all the information needed to use ZIDOVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for ZIDOVUDINE ORAL SOLUTION. ZIDOVUDINE oral solution Initial U.S. Approval: 1987 | Product name | Aurobindo Pharma Limited | 2025-02-10 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Coupler LLC | Strides Pharma Science Limited | 2025-02-06 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited | 2025-01-09 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2025-01-09 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE Tablets Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2025-01-09 |
| These highlights do not include all the information needed to use RETROVIR safely and effectively. See full prescribing information for RETROVIR. RETROVIR (zidovudine) capsules, for oral use RETROVIR (zidovudine) oral solution RETROVIR (zidovudine) injection, for intravenous use Initial U.S. Approval: 1987 | Product name | ViiV Healthcare Company | 2024-11-13 |
| These highlights do not include all the information needed to use RETROVIR safely and effectively. See full prescribing information for RETROVIR. RETROVIR (zidovudine) capsules, for oral use RETROVIR (zidovudine) oral solution RETROVIR (zidovudine) injection, for intravenous use Initial U.S. Approval: 1987 | Product name | ViiV Healthcare Company | 2024-11-13 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | Product name | PD-Rx Pharmaceuticals, Inc. | 2024-10-16 |
| These highlights do not include all the information needed to use NEVIRAPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE EXTENDED-RELEASE TABLETS. NEVIRAPINE extended-release tablets, for oral use Initial U.S. Approval: 1996 | Product name | Mylan Pharmaceuticals Inc. | 2024-10-15 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | American Health Packaging | 2024-09-16 |
| These highlights do not include all the information needed to use NEVIRAPINE ORAL SUSPENSION safely and effectively. See full prescribing information for NEVIRAPINE ORAL SUSPENSION. NEVIRAPINE oral suspension Initial U.S. Approval: 1996 | Product name | Aurobindo Pharma Limited | 2024-09-04 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) tablets, for oral use EPIVIR (lamivudine) oral solution Initial U.S. Approval: 1995 | Product name | ViiV Healthcare Company | 2024-08-15 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) tablets, for oral use EPIVIR (lamivudine) oral solution Initial U.S. Approval: 1995 | Product name | ViiV Healthcare Company | 2024-08-15 |
| These highlights do not include all the information needed to use NEVIRAPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE EXTENDED-RELEASE TABLETS. NEVIRAPINE extended-release tablets, for oral use Initial U.S. Approval: 1996 | Product name | Macleods Pharmaceuticals Limited | 2024-08-14 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | Product name | ViiV Healthcare Company | 2024-07-08 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | Product name | ViiV Healthcare Company | 2024-07-08 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | Aurobindo Pharma Limited | 2024-05-24 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Aurobindo Pharma Limited | 2024-05-20 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Aurobindo Pharma Limited | 2024-05-19 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2024-05-07 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Aurobindo Pharma Limited | 2024-04-29 |
| These highlights do not include all the information needed to use DOVATO safely and effectively. See full prescribing information for DOVATO. DOVATO (dolutegravir and lamivudine) tablets, for oral use Initial U.S. Approval: 2019 | Product name | ViiV Healthcare Company | 2024-04-18 |
| These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution, for oral use Initial U.S. Approval: 1995 | Product name | Aurobindo Pharma Limited | 2024-04-16 |
| These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution, for oral use Initial U.S. Approval: 1995 | Product name | Rising Pharma Holdings, Inc. | Aurobindo Pharma Limited | 2024-04-16 |
| These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | Bryant Ranch Prepack | 2024-04-05 |
| These highlights do not include all the information needed to use ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for ZIDOVUDINE TABLETS. ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1987 | Product name | Aurobindo Pharma Limited | 2024-01-25 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Mylan Pharmaceuticals Inc. | 2024-01-15 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2024-01-03 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2023-11-15 |
| These highlights do not include all the information needed to use ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS. ABACAVIR, LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 2000 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2023-10-31 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2023-10-30 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine tablets), for oral use Initial U.S. Approval: 1997 | Product name | ViiV Healthcare Company | 2023-08-22 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Product name | Macleods Pharmaceuticals Limited | 2023-08-16 |
| These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | Macleods Pharmaceuticals Limited | 2023-07-13 |
| These highlights do not include all the information needed to use ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for ZIDOVUDINE TABLETS. ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1987 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 2023-05-15 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets USP, for oral use Initial U.S. Approval: 1997 | Product name | Bryant Ranch Prepack | 2023-03-29 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | XLCare Pharmaceuticals, Inc | Ascent pharmaceuticals, Inc | 2023-01-16 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Macleods Pharmaceuticals Limited | 2022-12-01 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | Hetero Labs Limited Unit III | 2022-09-16 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, USP for oral use. Initial U.S. Approval: 1996 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 2022-08-03 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS ABACAVIR and LAMIVUIDNE Tablets, for oral use Initial U.S. Approval:2004 | Product name | Cipla USA Inc. | Cipla Ltd. Patalganga unit II | 2022-01-18 |
| These highlights do not include all the information needed to use CIMDUO safely and effectively. See full prescribing information for CIMDUO . CIMDUO ® (lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Viatris Specialty LLC | 2021-02-15 |
| These highlights do not include all the information needed to use SYMFI LO safely and effectively. See full prescribing information for SYMFI LO . SYMFI LO ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Viatris Specialty LLC | 2019-10-15 |
| These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Viatris Specialty LLC | 2019-10-15 |
| These highlights do not include all the information needed to use lamivudine and zidovudine safely and effectively. See full prescribing information for lamivudine and zidovudine. Lamivudine and Zidovudine Tablets, USP Initial U.S. Approval: 1997 | Product name | Exelan Pharmaceuticals Inc. | Ascent Pharmaceuticals Inc. | 2019-01-01 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets for Oral use. Initial U.S. Approval: 1995 | Product name | Ingenus Pharmaceuticals, LLC | Arise Pharmaceuticals LLC | Appco Pharma LLC | 2018-12-24 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE Tablets USP, 200 mg, for oral use Initial U.S. Approval: 1996 | Product name | Cipla Ltd. | Cipla Ltd.- Goa | 2018-11-27 |
| These highlights do not include all the information needed to use Zidovudine safely and effectively. See full prescribing information for Zidovudine. ZIDOVUDINE Syrup [zidovudine oral solution] 50mg/5mL, for oral use Rx only Initial U.S. Approval: 1987 | Product name | Cipla Ltd. | Cipla Limited- Indore | 2018-11-27 |
| These highlights do not include all the information needed to use lamivudine and zidovudine tablets safely and effectively. See full prescribing information for lamivudine and zidovudine tablets. lamivudine and zidovudine tablets Initial U.S. Approval: 1997 | Product name | Shanghai Desano Bio-Pharmaceutical Co., Ltd. | 2018-05-18 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Centaur Pharmaceuticals Private Limited | 2017-06-22 |
| These highlights do not include all the information needed to use ZIDOVUDINE . See full prescribing information for ZIDOVUDINE. Initial U.S. Approval 1987 | Product name | DOH CENTRAL PHARMACY | 2017-01-20 |
| Lamivudine Zidovudine | Product name | Direct Rx | 2016-06-22 |
| These highlights do not include all the information needed to use LAMIVUDINE Oral Solution, USP safely and effectively. See full prescribing information for LAMIVUDINE Oral Solution, USP LAMIVUDINE Oral Solution, USP for oral use Initial U.S. Approval: 1995 | Product name | Marlex Pharmaceuticals Inc | 2016-01-31 |
| These highlights do not include all the information needed to use nevirapine tablets, USP safely and effectively. See full prescribing information for nevirapine tablets, USP. Nevirapine tablets, USP 200 mg, for oral use Initial U.S. Approval: 1996 | Product name | State of Florida DOH Central Pharmacy | 2015-01-10 |
| These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000 | Product name | State of Florida DOH Central Pharmacy | 2014-04-24 |
| These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV. EPIVIR-HBV (lamivudine) tablets for oral use EPIVIR-HBV (lamivudine) oral solution Initial U.S. Approval: 1995 | Product name | State of Florida DOH Central Pharmacy | 2014-03-03 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | Product name | State of Florida DOH Central Pharmacy | 2014-02-27 |
| These highlights do not include all the information needed to use zidovudine tablets safely and effectively. See full prescribing information for zidovudine tablets. Zidovudine Tablets, USP Initial U.S. Approval: 1987 | Product name | State of Florida DOH Central Pharmacy | 2013-10-01 |
| These highlights do not include all the information needed to use nevirapine tablets safely and effectively. See full prescribing information for nevirapine tablets. Nevirapine Tablets USP, 200 mg Initial U.S. Approval: 1996 | Product name | State of Florida DOH Central Pharmacy | 2013-09-26 |
| These highlights do not include all the information needed to use lamivudine tablets safely and effectively. See full prescribing information for lamivudine tablets. Lamivudine Tablets 150 mg and 300 mg, for oral use Initial U.S. Approval: 1995 | Product name | State of Florida DOH Central Pharmacy | 2013-09-12 |
| These highlights do not include all the information needed to use VIRAMUNE XR safely and effectively. See full prescribing information for VIRAMUNE XR. Viramune XR® (nevirapine) Extended-Release Tablets, for oral use Initial U.S. Approval: 1996 | Product name | Physicians Total Care, Inc. | 2013-02-06 |
| These highlights do not include all the information needed to use Nevirapine safely and effectively. See full prescribing information for Nevirapine. Nevirapine Tablets, USP 200 mg for oral use Initial U.S. Approval: 1996 | Product name | Amneal Pharmaceuticals LLC | Strides Arcolab Limited | 2012-08-30 |
| These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997 | Product name | H.J. Harkins Company, Inc. | 2012-06-25 |
| These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997 | Product name | Rebel Distributors Corp | 2012-04-04 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | Product name | H.J. Harkins Company, Inc. | 2012-02-02 |
| These highlights do not include all the information needed to use ZIDOVUDINE . See full prescribing information for ZIDOVUDINE. Initial U.S. Approval: 1987 | Product name | Rebel Distributors Corp | 2011-01-26 |
| These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | Product name | Rebel Distributors Corp | 2010-09-24 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995 | Product name | Rebel Distributors Corp | 2010-09-24 |
| EPZICOM ® (abacavir sulfate and lamivudine) Tablets | Product name | Physicians Total Care, Inc. | 2010-07-01 |
| These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. Viramune® (nevirapine) tablets 200 mg Viramune® (nevirapine) oral suspension 50 mg/5 mL Initial U.S. Approval: 1996 | Product name | State of Florida DOH Central Pharmacy | 2010-05-21 |
| EPZICOM ® (abacavir sulfate and lamivudine) Tablets | Product name | State of Florida DOH Central Pharmacy | 2010-05-11 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995 | Product name | Physicians Total Care, Inc. | 2010-04-14 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) Tablets and Oral Solution Initial U.S. Approval: 1995 | Product name | State of Florida DOH Central Pharmacy | 2010-04-13 |
| COMBIVIR (lamivudine and zidovudine) tablet, film coated | Product name | Stat Rx USA | 2009-10-27 |